Mutagenetix > Incidental Mutation

Incidental Mutation 'R0432:Chrm5'

38810

Institutional Source

Beutler Lab

Gene Symbol

Chrm5

Ensembl Gene

ENSMUSG00000074939

Gene Name

cholinergic receptor, muscarinic 5

Synonyms

muscarinic acetylcholine receptor 5, M5R

MMRRC Submission

038634-MU

Accession Numbers

Essential gene?

Probably non essential (E-score: 0.082) question?

Stock #

R0432 (G1)

Quality Score

225

Status

Validated

Chromosome

Chromosomal Location

112309516-112311114 bp(-) (GRCm39)

Type of Mutation

missense

DNA Base Change (assembly)

T to A at 112310000 bp (GRCm39)

Zygosity

Heterozygous

Amino Acid Change

Lysine to Methionine at position 372 (K372M)

Ref Sequence

ENSEMBL: ENSMUSP00000097185 (fasta)

Gene Model

predicted gene model for transcript(s): [ENSMUST00000099589]

AlphaFold

Q920H4

Predicted Effect

possibly damaging
Transcript: ENSMUST00000099589
AA Change: K372M

PolyPhen 2 Score 0.762 (Sensitivity: 0.85; Specificity: 0.92)

SMART Domains

Protein: ENSMUSP00000097185
Gene: ENSMUSG00000074939
AA Change: K372M

Domain	Start	End	E-Value	Type
Pfam:7TM_GPCR_Srx	38	242	2.3e-8	PFAM
Pfam:7TM_GPCR_Srsx	41	253	7.5e-8	PFAM
Pfam:7tm_1	47	495	1.5e-79	PFAM
low complexity region	507	518	N/A	INTRINSIC

Meta Mutation Damage Score

0.0830

Coding Region Coverage

1x: 99.2%
3x: 98.3%
10x: 96.3%
20x: 92.9%

Validation Efficiency

99% (91/92)

MGI Phenotype

FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The muscarinic cholinergic receptors belong to a larger family of G protein-coupled receptors. The functional diversity of these receptors is defined by the binding of acetylcholine and includes cellular responses such as adenylate cyclase inhibition, phosphoinositide degeneration, and potassium channel mediation. Muscarinic receptors influence many effects of acetylcholine in the central and peripheral nervous system. The clinical implications of this receptor are unknown; however, stimulation of this receptor is known to increase cyclic AMP levels. [provided by RefSeq, Jul 2008]
PHENOTYPE: Homozygotes for a targeted null allele exhibit loss of acetylcholine-induced dilation of cerebral arteries, decreased pilocarpine-induced salivation, increased water-deprivation induced drinking, and attenuated morphine reinforcement and withdrawal. [provided by MGI curators]

Allele List at MGI

All alleles(3) : Targeted, knock-out(3)

Other mutations in this stock

Total: 88 list
Gene	Ref	Var	Chr/Loc	Mutation	Predicted Effect	Zygosity
2310061I04Rik	A	G	17: 36,206,708 (GRCm39)	L110P	probably damaging	Het
4930522L14Rik	A	T	5: 109,884,785 (GRCm39)	C358S	probably damaging	Het
Abca8b	C	A	11: 109,870,841 (GRCm39)	V104F	possibly damaging	Het
Afap1l2	T	C	19: 56,905,551 (GRCm39)		probably benign	Het
Ahctf1	A	C	1: 179,611,726 (GRCm39)	I548R	probably damaging	Het
Alox12b	G	T	11: 69,060,382 (GRCm39)	G646V	probably damaging	Het
Aoah	C	T	13: 21,095,368 (GRCm39)		probably benign	Het
Arhgap39	C	T	15: 76,619,086 (GRCm39)	D833N	probably damaging	Het
Atxn1l	A	G	8: 110,458,325 (GRCm39)	W646R	probably damaging	Het
Cabp2	T	C	19: 4,134,903 (GRCm39)	I28T	possibly damaging	Het
Cacna1b	G	A	2: 24,577,716 (GRCm39)	T719I	probably damaging	Het
Camk1d	A	T	2: 5,449,946 (GRCm39)	H70Q	probably damaging	Het
Car1	T	C	3: 14,835,236 (GRCm39)	T170A	probably benign	Het
Ccdc162	T	C	10: 41,417,856 (GRCm39)	T2113A	probably benign	Het
Cdc5l	G	A	17: 45,726,610 (GRCm39)	R321W	probably damaging	Het
Cdh17	T	A	4: 11,771,273 (GRCm39)	C18*	probably null	Het
Cdk17	A	T	10: 93,073,652 (GRCm39)		probably benign	Het
Chd9	T	A	8: 91,721,078 (GRCm39)		probably benign	Het
Clasp2	A	G	9: 113,738,487 (GRCm39)	T423A	probably benign	Het
Col11a1	A	G	3: 113,999,550 (GRCm39)		probably benign	Het
Col27a1	T	C	4: 63,143,848 (GRCm39)	M512T	possibly damaging	Het
Dclk3	A	G	9: 111,314,003 (GRCm39)	D693G	probably damaging	Het
Dcun1d3	T	A	7: 119,457,173 (GRCm39)	K180*	probably null	Het
Dmxl2	T	C	9: 54,324,235 (GRCm39)	R876G	probably benign	Het
Dnmbp	A	T	19: 43,843,296 (GRCm39)	Y432*	probably null	Het
Elapor2	G	T	5: 9,490,966 (GRCm39)	G659*	probably null	Het
Eml2	C	T	7: 18,913,456 (GRCm39)	Q125*	probably null	Het
Faap100	A	C	11: 120,264,702 (GRCm39)		probably benign	Het
Foxp2	T	C	6: 15,254,278 (GRCm39)		probably benign	Het
Gda	A	G	19: 21,394,471 (GRCm39)	Y129H	probably damaging	Het
Gga3	G	A	11: 115,481,350 (GRCm39)	R207C	probably damaging	Het
Glg1	T	C	8: 111,909,201 (GRCm39)	I496M	probably damaging	Het
Glt6d1	C	A	2: 25,684,739 (GRCm39)		probably null	Het
Gm10322	A	T	10: 59,452,030 (GRCm39)	H49L	possibly damaging	Het
Golga5	G	T	12: 102,442,467 (GRCm39)	V269F	possibly damaging	Het
Gramd2b	G	A	18: 56,607,141 (GRCm39)	C85Y	probably benign	Het
Grhl1	C	T	12: 24,632,918 (GRCm39)	P153L	probably benign	Het
Hdac9	T	C	12: 34,487,221 (GRCm39)	Q60R	probably damaging	Het
Hdlbp	T	C	1: 93,353,054 (GRCm39)	I414V	probably damaging	Het
Itpk1	C	T	12: 102,572,337 (GRCm39)		probably benign	Het
Itsn1	T	A	16: 91,612,408 (GRCm39)	Y266N	probably damaging	Het
Lipe	G	A	7: 25,097,913 (GRCm39)	P10L	probably benign	Het
Lrrc8a	A	G	2: 30,147,079 (GRCm39)	E631G	probably damaging	Het
Lvrn	T	A	18: 47,038,366 (GRCm39)	N973K	possibly damaging	Het
Man2c1	T	A	9: 57,042,881 (GRCm39)	H250Q	probably damaging	Het
Mup3	T	C	4: 62,003,519 (GRCm39)	T117A	probably benign	Het
Myo6	A	C	9: 80,181,256 (GRCm39)		probably benign	Het
Nbn	T	A	4: 15,983,951 (GRCm39)		probably benign	Het
Ncapg	T	A	5: 45,829,770 (GRCm39)	N157K	probably damaging	Het
Or4p7	C	T	2: 88,222,377 (GRCm39)	T262I	probably damaging	Het
Or5an1	T	A	19: 12,261,267 (GRCm39)	M285K	probably damaging	Het
Or5m12	T	A	2: 85,734,501 (GRCm39)	N299I	probably damaging	Het
Or5w14	G	A	2: 87,541,774 (GRCm39)	H159Y	probably benign	Het
Or9m1	T	C	2: 87,733,304 (GRCm39)	T239A	probably damaging	Het
P4ha1	T	A	10: 59,184,079 (GRCm39)	Y180*	probably null	Het
Pcdhb19	T	A	18: 37,632,588 (GRCm39)	F794L	probably benign	Het
Pdxdc1	T	A	16: 13,672,264 (GRCm39)	I379F	probably damaging	Het
Psme3	T	A	11: 101,211,268 (GRCm39)	S185T	possibly damaging	Het
Ptgr1	A	G	4: 58,978,045 (GRCm39)	S116P	probably damaging	Het
Ptpn23	A	T	9: 110,218,078 (GRCm39)		probably null	Het
Rabgap1l	A	C	1: 160,549,775 (GRCm39)	I277R	probably benign	Het
Rapgef1	C	T	2: 29,569,828 (GRCm39)	T93I	possibly damaging	Het
Rbp3	A	T	14: 33,676,730 (GRCm39)	D226V	probably damaging	Het
Rnf144a	A	T	12: 26,389,328 (GRCm39)	C38S	probably damaging	Het
Rptor	C	T	11: 119,671,379 (GRCm39)	Q281*	probably null	Het
Rragd	T	C	4: 33,004,332 (GRCm39)	L208S	probably damaging	Het
Slc12a4	T	C	8: 106,686,120 (GRCm39)	E41G	probably damaging	Het
Slc16a1	G	T	3: 104,560,735 (GRCm39)	V347F	probably benign	Het
Slit1	G	A	19: 41,731,732 (GRCm39)	T39I	probably damaging	Het
Sra1	T	C	18: 36,810,556 (GRCm39)	N98S	probably benign	Het
Ssx2ip	T	C	3: 146,132,184 (GRCm39)	L215P	probably damaging	Het
Syne2	A	T	12: 75,995,838 (GRCm39)	H2126L	probably damaging	Het
Tep1	TTTCTTCTTCTT	TTTCTTCTT	14: 51,104,280 (GRCm39)		probably benign	Het
Tgfbi	T	C	13: 56,780,004 (GRCm39)		probably benign	Het
Tmem232	T	C	17: 65,563,498 (GRCm39)	M632V	probably damaging	Het
Tmem81	C	G	1: 132,435,567 (GRCm39)	I124M	probably damaging	Het
Tnnt3	T	G	7: 142,065,823 (GRCm39)	D153E	probably benign	Het
Tnrc6b	T	A	15: 80,807,647 (GRCm39)		probably benign	Het
Tpsab1	A	G	17: 25,562,798 (GRCm39)		probably benign	Het
Usp34	T	A	11: 23,351,505 (GRCm39)	V1431D	probably damaging	Het
Wdr49	G	T	3: 75,357,329 (GRCm39)	R285S	possibly damaging	Het
Wdr7	A	G	18: 63,929,320 (GRCm39)	Y1052C	probably damaging	Het
Zan	A	T	5: 137,380,578 (GRCm39)		probably benign	Het
Zfp652	G	A	11: 95,654,565 (GRCm39)	V323I	possibly damaging	Het
Zfp740	A	G	15: 102,121,094 (GRCm39)	T136A	possibly damaging	Het
Zfp82	C	T	7: 29,755,754 (GRCm39)	E443K	probably damaging	Het
Zfp874b	A	G	13: 67,629,955 (GRCm39)	S10P	probably damaging	Het
Zmynd19	A	G	2: 24,848,134 (GRCm39)	Y110C	probably benign	Het

Other mutations in Chrm5

Allele	Source	Chr	Coord	Type	Predicted Effect	PPH Score
IGL01532:Chrm5	APN	2	112,309,577 (GRCm39)	missense	probably benign
IGL01611:Chrm5	APN	2	112,310,651 (GRCm39)	nonsense	probably null
IGL02152:Chrm5	APN	2	112,310,913 (GRCm39)	missense	probably damaging	1.00
IGL03002:Chrm5	APN	2	112,310,706 (GRCm39)	missense	probably damaging	1.00
C9142:Chrm5	UTSW	2	112,310,556 (GRCm39)	missense	probably damaging	1.00
R0200:Chrm5	UTSW	2	112,311,065 (GRCm39)	missense	probably benign
R1158:Chrm5	UTSW	2	112,310,214 (GRCm39)	missense	probably benign	0.00
R1611:Chrm5	UTSW	2	112,309,532 (GRCm39)	missense	possibly damaging	0.74
R1621:Chrm5	UTSW	2	112,310,182 (GRCm39)	missense	probably benign	0.00
R1693:Chrm5	UTSW	2	112,309,625 (GRCm39)	missense	probably damaging	1.00
R1988:Chrm5	UTSW	2	112,310,597 (GRCm39)	missense	probably damaging	0.99
R1989:Chrm5	UTSW	2	112,310,597 (GRCm39)	missense	probably damaging	0.99
R2071:Chrm5	UTSW	2	112,309,572 (GRCm39)	missense	probably null	0.93
R2890:Chrm5	UTSW	2	112,310,048 (GRCm39)	missense	probably benign	0.00
R4659:Chrm5	UTSW	2	112,310,102 (GRCm39)	missense	probably benign
R4785:Chrm5	UTSW	2	112,309,930 (GRCm39)	missense	probably benign	0.25
R5196:Chrm5	UTSW	2	112,310,729 (GRCm39)	missense	probably damaging	1.00
R5734:Chrm5	UTSW	2	112,310,445 (GRCm39)	missense	probably benign	0.28
R6343:Chrm5	UTSW	2	112,309,793 (GRCm39)	missense	probably damaging	1.00
R6499:Chrm5	UTSW	2	112,310,825 (GRCm39)	missense	probably benign
R6672:Chrm5	UTSW	2	112,310,141 (GRCm39)	missense	probably benign
R6905:Chrm5	UTSW	2	112,309,901 (GRCm39)	missense	probably benign	0.00
R7192:Chrm5	UTSW	2	112,310,672 (GRCm39)	missense	probably damaging	0.97
R7775:Chrm5	UTSW	2	112,310,301 (GRCm39)	missense	probably benign	0.07
R7778:Chrm5	UTSW	2	112,310,301 (GRCm39)	missense	probably benign	0.07
R8780:Chrm5	UTSW	2	112,310,453 (GRCm39)	missense	possibly damaging	0.64
R9287:Chrm5	UTSW	2	112,309,610 (GRCm39)	missense	probably damaging	1.00
R9436:Chrm5	UTSW	2	112,309,824 (GRCm39)	missense	possibly damaging	0.69
R9502:Chrm5	UTSW	2	112,311,040 (GRCm39)	missense	probably damaging	1.00
X0023:Chrm5	UTSW	2	112,310,826 (GRCm39)	missense	probably benign

Predicted Primers

PCR Primer
(F):5'- GTTGACATAGCACAGCCAGTAACCC -3'
(R):5'- CCCTGTCTTTCAAGTGGTCTGCAAG -3'

Sequencing Primer
(F):5'- AATGGCGCTCAAGGTCTG -3'
(R):5'- CTTTCAAGTGGTCTGCAAGAATGAG -3'

Posted On

2013-05-23